| Phosphorescent molecular butterflies with controlled potential-energy surfaces and their application as luminescent viscosity sensor C Zhou, L Yuan, Z Yuan, NK Doyle, T Dilbeck, D Bahadur, ... Inorganic Chemistry 55 (17), 8564-8569, 2016 | 47 | 2016 |
| Beyond the new normal: Assessing the feasibility of vaccine-based suppression of SARS-CoV-2 M Stoddard, S Sarkar, L Yuan, RP Nolan, DE White, LF White, ... Plos one 16 (7), e0254734, 2021 | 14 | 2021 |
| Using mixed-effects modeling to estimate decay kinetics of response to SARS-CoV-2 infection D Bottino, G Hather, L Yuan, M Stoddard, L White, A Chakravarty Antibody Therapeutics 4 (3), 144-148, 2021 | 7 | 2021 |
| Heterogeneity in vaccinal immunity to SARS-CoV-2 can be addressed by a personalized booster strategy M Stoddard, L Yuan, S Sarkar, S Mangalaganesh, RP Nolan, D Bottino, ... Vaccines 11 (4), 806, 2023 | 5 | 2023 |
| The gray swan: model-based assessment of the risk of sudden failure of hybrid immunity to SARS-CoV-2 M Stoddard, L Yuan, S Sarkar, D Van Egeren, LF White, A Chakravarty medRxiv, 2023.02. 26.23286471, 2023 | 2 | 2023 |
| The impact of vaccination frequency on COVID-19 public health outcomes: A model-based analysis M Stoddard, L Yuan, S Sarkar, D van Egeren, S Mangalaganesh, ... medRxiv, 2023.01. 26.23285076, 2023 | 2 | 2023 |
| Shielding under endemic SARS-CoV-2 conditions is easier said than done: a model-based analysis M Stoddard, L Yuan, S Sarkar, M Mazewski, D van Egeren, ... medRxiv, 2023.01. 22.23284884, 2023 | 2 | 2023 |
| Using translational in vitro-in vivo modeling to improve drug repurposing outcomes for inhaled COVID-19 therapeutics M Stoddard, L Yuan, A Chakravarty medRxiv, 2021.03. 11.21253375, 2021 | 1 | 2021 |
| Using game theory to investigate the therapeutic potential of disrupting tumor-microenvironment interactions D Van Egeren, A Chen, M Stoddard, L Yuan, A Chakravarty Cancer Research 84 (6_Supplement), 7378-7378, 2024 | | 2024 |
| Model-derived progression-free survival (mPFS): A better metric for patient-derived xenograft studies A Chen, M Stoddard, L Yuan, D Van Egeren, A Chakravarty, D Bottino Cancer Research 84 (6_Supplement), 6904-6904, 2024 | | 2024 |
| Understanding three-drug combinations: optimizing scheduling while avoiding toxicity M Stoddard, L Yuan, D Van Egeren, A Chen, D Bottino, A Chakravarty Cancer Research 84 (6_Supplement), 4761-4761, 2024 | | 2024 |
| Impact of drug combination schedules on the evolution of tumor resistance M Stoddard, A Chen, L Yuan, D Van Egeren, D Bottino, A Chakravarty Cancer Research 84 (6_Supplement), 4310-4310, 2024 | | 2024 |
| Towards better prediction of treatment resistance: Directly modeling progression from multiple lesions S Protich, M Stoddard, L Yuan, D White, D Bottino, A Chakravarty Cancer Research 84 (6_Supplement), 2391-2391, 2024 | | 2024 |
| Blood brain barrier masks effects of dosing strategy M Stoddard, A Chen, L Yuan, D Van Egeren, A Chakravarty Cancer Research 84 (6_Supplement), 7182-7182, 2024 | | 2024 |
| Shielding under endemic SARS-CoV-2 conditions is easier said than done: a model-based analysis (preprint) M Stoddard, L Yuan, S Sarkar, M Mazewski, D Van Egeren, ... | | 2023 |
| The gray swan: model-based assessment of the risk of sudden failure of hybrid immunity to SARS-CoV-2 (preprint) M Stoddard, L Yuan, S Sarkar, D Van Egeren, L White, A Chakravarty | | 2023 |
| The impact of vaccination frequency on COVID-19 public health outcomes: A model-based analysis (preprint) M Stoddard, L Yuan, S Sarkar, D Van Egeren, S Mangalaganesh, ... | | 2023 |
| Heterogeneity in vaccinal immunity to SARS-CoV-2 can be addressed by a personalized booster strategy (preprint) M Stoddard, L Yuan, S Sarkar, S Mangalaganesh, RP Nolan, D Bottino, ... | | 2022 |
| Using translational in vitro-in vivo modeling to improve drug repurposing outcomes for inhaled COVID-19 therapeutics (preprint) M Stoddard, L Yuan, A Chakravarty | | 2021 |
| Using mixed-effects modeling to estimate decay kinetics of response to SARS-CoV-2 infection (preprint) D Bottino, G Hather, L Yuan, M Stoddard, L White, A Chakravarty | | 2021 |
